A fluorescence-based assay for the uptake of CPD0801 (DB829) by African trypanosomes
- 31 December 2010
- journal article
- research article
- Published by Elsevier in Molecular and Biochemical Parasitology
- Vol. 174 (2) , 145-149
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- New Treatment Option for Second-Stage African Sleeping Sickness: In Vitro and In Vivo Efficacy of Aza Analogs of DB289Antimicrobial Agents and Chemotherapy, 2009
- Effectiveness of melarsoprol and eflornithine as first-line regimens for gambiense sleeping sickness in nine Médecins Sans Frontières programmesTransactions of the Royal Society of Tropical Medicine and Hygiene, 2009
- The continuing problem of human African trypanosomiasis (sleeping sickness)Annals of Neurology, 2008
- Eliminating Human African Trypanosomiasis: Where Do We Stand and What Comes Next?PLOS Medicine, 2008
- Roles for the Trypanosoma brucei P2 Transporter in DB75 Uptake and ResistanceMolecular Pharmacology, 2006
- The Trypanocide Diminazene Aceturate Is Accumulated Predominantly through the TbAT1 Purine Transporter: Additional Insights on Diamidine Resistance in African TrypanosomesAntimicrobial Agents and Chemotherapy, 2004
- Pentamidine uptake and resistance in pathogenic protozoa: past, present and futureTrends in Parasitology, 2003
- Uptake of pentamidine in Trypanosoma brucei brucei is mediated by the P2 adenosine transporter and at least one novel, unrelated transporterActa Tropica, 2001
- Genetic variants of the TbAT1 adenosine transporter from African trypanosomes in relapse infections following melarsoprol therapyMolecular and Biochemical Parasitology, 2001
- Arsenical-resistant trypanosomes lack an unusual adenosine transporterNature, 1993